Peroxisome proliferator-activated receptor α (PPARα) activators induce hepatic farnesyl diphosphate synthase gene expression in rodents

Zimetbaum, 1991, Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins, J. Clin. Pharmacol., 31, 25, 10.1002/j.1552-4604.1991.tb01883.x Sirtori, 1988, Effects of fibrates on serum lipids and atherosclerosis, Pharmacol. Ther., 37, 167, 10.1016/0163-7258(88)90024-1 Kersten, 2000, Peroxisome proliferator activated receptor agonists, EXS, 89, 141 Reddy, 1996, Peroxisome proliferator induced pleiotropic responses: pursuit of a phenomenon, Ann. N.Y. Acad. Sci., 804, 176, 10.1111/j.1749-6632.1996.tb18616.x Michalik, 1999, Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions, Curr. Opin. Biotechnol., 10, 564, 10.1016/S0958-1669(99)00030-0 Staels, 1998, Mechanism of action of fibrates on lipid and lipoprotein metabolism, Circulation, 98, 2088, 10.1161/01.CIR.98.19.2088 Fruchart, 1999, Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis, Curr. Opin. Lipidol., 10, 245, 10.1097/00041433-199906000-00007 Keller, 1993, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated-receptor-retinoid X receptor heterodimers, Proc. Natl. Acad. Sci. U.S.A., 90, 2160, 10.1073/pnas.90.6.2160 Issemann, 1993, The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolidaemic drugs, J. Mol. Endocrinol., 11, 37, 10.1677/jme.0.0110037 Lalwani, 1983, Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver, Hum. Toxicol., 2, 27, 10.1177/096032718300200103 Lock, 1989, Biochemical mechanisms of induction of hepatic peroxisome proliferation, Annu. Rev. Pharmacol. Toxicol., 29, 145, 10.1146/annurev.pa.29.040189.001045 Thangada, 1989, An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate, FEBS Lett., 250, 205, 10.1016/0014-5793(89)80721-5 Lee, 1995, Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol. Cell. Biol., 15, 3012, 10.1128/MCB.15.6.3012 Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest., 109, 1125, 10.1172/JCI0215593 Vallett, 1996, A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene, J. Biol. Chem., 271, 12247, 10.1074/jbc.271.21.12247 Ericsson, 1996, Sterol regulatory element binding protein binds to a cis element in the promoter of the FPP synthase gene, Proc. Natl. Acad. Sci. U.S.A., 93, 945, 10.1073/pnas.93.2.945 Nohturfft, 2000, Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes, Cell, 102, 315, 10.1016/S0092-8674(00)00037-4 Brown, 2002, Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism, Mol. Cell, 10, 237, 10.1016/S1097-2765(02)00591-9 Pai, 1998, Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins, J. Biol. Chem., 273, 26138, 10.1074/jbc.273.40.26138 Costet, 1998, Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis, J. Biol. Chem., 273, 29577, 10.1074/jbc.273.45.29577 Patel, 2001, Disturbances in the normal regulation of SREBP-sensitive genes in PPARalpha-deficient mice, J. Lipid Res., 42, 328, 10.1016/S0022-2275(20)31655-2 Gibbons, 2002, The functional efficiency of lipogenic and cholesterogenic gene expression in normal mice and in mice lacking the peroxisomal proliferator-activated receptor-alpha (PPAR-alpha), Adv. Enzyme Regul., 42, 227, 10.1016/S0065-2571(01)00033-4 Hashimoto, 1995, Effect of gemfibrozil on lipid biosynthesis from acetyl-CoA derived from peroxisomal beta-oxidation, Biochem. Pharmacol., 49, 1213, 10.1016/0006-2952(95)00041-W Roglans, 2001, Increase in hepatic expression of SREBP-2 by gemfibrozil administration to rats, Biochem. Pharmacol., 62, 803, 10.1016/S0006-2952(01)00701-8 Maxwell, 1983, Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats, Atherosclerosis, 48, 195, 10.1016/0021-9150(83)90038-2 Haughom, 1992, The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooactane sulphonic acid (PFOSA) and clofibric acid, Biochim. Biophys. Acta, 1128, 65, 10.1016/0005-2760(92)90258-W Hashimoto, 2000, Changes in isoprenoid lipid synthesis by gemfibrozil and clofibric acid in rat hepatocytes, Biochem. Pharmacol., 59, 1203, 10.1016/S0006-2952(00)00261-6 Stahlberg, 1989, Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes, J. Lipid Res., 30, 953, 10.1016/S0022-2275(20)38297-3 Johnson, 2001, Peroxisome proliferators and fatty acids negatively regulate liver X receptor-mediated activity and sterol biosynthesis, J. Steroid Biochem. Mol. Biol., 77, 59, 10.1016/S0960-0760(01)00027-9 Stahlberg, 1995, Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7alpha-hydroxylase, Hepatology, 21, 1025 Stange, 1991, Inhibition of HMG-CoA reductase in mononuclear cells during gemfibrozil treatment, Atherosclerosis, 91, 257, 10.1016/0021-9150(91)90173-Z Cosentini, 1989, Inhibition of cholesterol biosynthesis in freshly isolated blood mononuclear cells from normolipidemic subjects and hypercholesterolemic patients treated with bezafibrate, Atherosclerosis, 79, 253, 10.1016/0021-9150(89)90131-7 Seglen, 1973, Preparation of rat liver cells: Enzymatic requirements for tissue dispersion, Exp. Cell Res., 82, 391, 10.1016/0014-4827(73)90357-1 Elcombe, 1986, Peroxisome proliferation due to di(2-ethylhexyl)phthalate (DEHP): Species differences and possible mechanisms, Environ. Health Perspect., 70, 211, 10.1289/ehp.8670211 Krisans, 1994, Farnesyl-diphosphate synthase is localized in peroxisomes, J. Biol. Chem., 269, 14165, 10.1016/S0021-9258(17)36769-8 Reddy, 1986, Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-dehydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators, Proc. Natl. Acad. Sci. U.S.A., 83, 1747, 10.1073/pnas.83.6.1747 Duclos, 1997, Peroxisome proliferation and β-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured hepatocytes: effect of ciprofibrate, Eur. J. Cell Biol., 72, 314 Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2 Krey, 1997, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Mol. Endocrinol., 11, 779, 10.1210/me.11.6.779 Bell, 1991, Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators, Biochem. J., 280, 249, 10.1042/bj2800249 Rodriguez, 2001, Differential induction of stearoyl-CoA desaturase and acyl-CoA oxidase genes by fibrates in HepG2 cells, Biochem. Pharmacol., 61, 357, 10.1016/S0006-2952(00)00557-8 Iida, 2002, PPAR gamma ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages, FEBS Left., 520, 177, 10.1016/S0014-5793(02)02811-9 Turunen, 2000, Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis, J. Mol. Biol., 297, 607, 10.1006/jmbi.2000.3596 Spear, 1992, Molecular cloning and promoter analysis of the rat liver farnesyl diphosphate synthase gene, J. Biol. Chem., 267, 14462, 10.1016/S0021-9258(19)49735-4 Qi, 1999, Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/l-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism, J. Biol. Chem., 274, 15775, 10.1074/jbc.274.22.15775 Kok, 2003, Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice, Biochem. J., 369, 539, 10.1042/bj20020981 Leiss, 1986, Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate, J. Lipid Res., 27, 213 Lehmann, 1997, Activation of the nuclear receptor LXR by oxysterols definies a new hormone response pathway, J. Biol. Chem., 272, 3137, 10.1074/jbc.272.6.3137 Peet, 1998, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha, Cell, 93, 693, 10.1016/S0092-8674(00)81432-4 Miyata, 1996, The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling, J. Biol. Chem., 271, 9189, 10.1074/jbc.271.16.9189